CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 991 of 1
Non-Antibody Products
Page 991 of 1,297
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| (±)-trans-1,2-Bis(2-mercaptoacetamido)cyclohexane | A dithiol used, both in vitro and in vivo, to promote the correct folding… | 50 mg | 17249-50 | More Info |
| (±)trans-2,5-bis-(3,4,5-Trimethoxyphenyl)-1,3-dioxolane | trans-BTP Dioxolane is a PAF receptor antagonist. This compound demonstrat… | 1 mg | 60950-1 | More Info |
| (±)trans-2,5-bis-(3,4,5-Trimethoxyphenyl)-1,3-dioxolane | trans-BTP Dioxolane is a PAF receptor antagonist. This compound demonstrat… | 10 mg | 60950-10 | More Info |
| (±)trans-2,5-bis-(3,4,5-Trimethoxyphenyl)-1,3-dioxolane | trans-BTP Dioxolane is a PAF receptor antagonist. This compound demonstrat… | 5 mg | 60950-5 | More Info |
| (±)-trans-GK563 | A GVIA iPLA2 inhibitor (IC50 = 1 nM); selective for GVIA iPLA2 over GVIA c… | 1 mg | 25732-1 | More Info |
| (±)-trans-GK563 | A GVIA iPLA2 inhibitor (IC50 = 1 nM); selective for GVIA iPLA2 over GVIA c… | 10 mg | 25732-10 | More Info |
| (±)-trans-GK563 | A GVIA iPLA2 inhibitor (IC50 = 1 nM); selective for GVIA iPLA2 over GVIA c… | 5 mg | 25732-5 | More Info |
| (±)-trans-3-methyl Fentanyl (hydrochloride) (exempt preparation) | An analytical reference standard categorized as an opioid; provided as an… | 100 µg | 39199-100 | More Info |
| (±)-trans-3-methyl Norfentanyl | An opioid whose physiological and toxicological properties are not known, | 1 mg | 22695-1 | More Info |
| (±)-trans-3-methyl Norfentanyl | An opioid whose physiological and toxicological properties are not known, | 5 mg | 22695-5 | More Info |
| (±)-trans-3-methyl Thiofentanyl (hydrochloride) | An analytical reference standard structurally similar to known opioids; re… | 1 mg | 22241-1 | More Info |
| (±)-trans-3-methyl Thiofentanyl (hydrochloride) | An analytical reference standard structurally similar to known opioids; re… | 5 mg | 22241-5 | More Info |
| (±)-Tuberonic Acid | A derivative of jasmonic acid | 1 mg | 35750-1 | More Info |
| (±)-Tuberonic Acid | A derivative of jasmonic acid | 10 mg | 35750-10 | More Info |
| (±)-Tuberonic Acid | A derivative of jasmonic acid | 25 mg | 35750-25 | More Info |
| (±)-Tuberonic Acid | A derivative of jasmonic acid | 5 mg | 35750-5 | More Info |
| (±)-Verapamil-d3 (hydrochloride) | An internal standard for the quantification of verapamil (hydrochloride) b… | 1 mg | 18452-1 | More Info |
| (±)-Verapamil-d3 (hydrochloride) | An internal standard for the quantification of verapamil (hydrochloride) b… | 5 mg | 18452-5 | More Info |
| (±)-Verapamil-d3 (hydrochloride) | An internal standard for the quantification of verapamil (hydrochloride) b… | 500 µg | 18452-500 | More Info |
| (±)-Warfarin | An anticoagulant; a vitamin K antagonist, a coumarin derivative, and a rac… | 1 g | 13566-1 | More Info |
| (±)-Warfarin-d5 | An internal standard for the quantification of warfarin by GC- or LC-MS | 1 mg | 25432-1 | More Info |
| (±)-Warfarin-d5 | An internal standard for the quantification of warfarin by GC- or LC-MS | 500 µg | 25432-500 | More Info |
| (±)-WIN 55,212 (mesylate) | A racemic mixture of (+)-WIN 55,212-2 and (−)-WIN 55,212-3; inhibits… | 10 mg | 10736-10 | More Info |
| (±)-WIN 55,212 (mesylate) | A racemic mixture of (+)-WIN 55,212-2 and (−)-WIN 55,212-3; inhibits… | 25 mg | 10736-25 | More Info |
| (±)-WIN 55,212 (mesylate) | A racemic mixture of (+)-WIN 55,212-2 and (−)-WIN 55,212-3; inhibits… | 5 mg | 10736-5 | More Info |
| (±)-WIN 55,212 (mesylate) | A racemic mixture of (+)-WIN 55,212-2 and (−)-WIN 55,212-3; inhibits… | 50 mg | 10736-50 | More Info |
| Pluviatolide | A lignan; scavenges ABTS and DPPH radicals in cell-free assays (IC50s = 23… | 1 mg | 29582-1 | More Info |
| Pluviatolide | A lignan; scavenges ABTS and DPPH radicals in cell-free assays (IC50s = 23… | 5 mg | 29582-5 | More Info |
| PLX4032 | An orally bioavailable, ATP-competitive inhibitor of mutant V600E and wild… | 10 mg | 10618-10 | More Info |
| PLX4032 | An orally bioavailable, ATP-competitive inhibitor of mutant V600E and wild… | 25 mg | 10618-25 | More Info |
| PLX4032 | An orally bioavailable, ATP-competitive inhibitor of mutant V600E and wild… | 5 mg | 10618-5 | More Info |
| PLX4032 | An orally bioavailable, ATP-competitive inhibitor of mutant V600E and wild… | 50 mg | 10618-50 | More Info |
| PLX4720 | An orally-available, highly selective inhibitor of B-RafV600E (IC50 = 13 n… | 1 mg | 15142-1 | More Info |
| PLX4720 | An orally-available, highly selective inhibitor of B-RafV600E (IC50 = 13 n… | 10 mg | 15142-10 | More Info |
| PLX4720 | An orally-available, highly selective inhibitor of B-RafV600E (IC50 = 13 n… | 25 mg | 15142-25 | More Info |
| PLX4720 | An orally-available, highly selective inhibitor of B-RafV600E (IC50 = 13 n… | 5 mg | 15142-5 | More Info |
| PLX51107 | A BET family protein inhibitor; binds to BD1 in BRD2, BRD3, BRD4, and BRDT… | 1 mg | 30742-1 | More Info |
| PLX51107 | A BET family protein inhibitor; binds to BD1 in BRD2, BRD3, BRD4, and BRDT… | 5 mg | 30742-5 | More Info |
| PLX51107 | A BET family protein inhibitor; binds to BD1 in BRD2, BRD3, BRD4, and BRDT… | 500 µg | 30742-500 | More Info |
| PLX5622 | A brain-penetrant CSF1R inhibitor (IC50 = 0.016 µM); selective for C… | 1 mg | 28927-1 | More Info |
| PLX5622 | A brain-penetrant CSF1R inhibitor (IC50 = 0.016 µM); selective for C… | 10 mg | 28927-10 | More Info |
| PLX5622 | A brain-penetrant CSF1R inhibitor (IC50 = 0.016 µM); selective for C… | 25 mg | 28927-25 | More Info |
| PLX5622 | A brain-penetrant CSF1R inhibitor (IC50 = 0.016 µM); selective for C… | 5 mg | 28927-5 | More Info |
| PLX647 | A dual inhibitor of FMS and KIT (IC50s = 28 and 16 nM, respectively); is s… | 10 mg | 18012-10 | More Info |
| PLX647 | A dual inhibitor of FMS and KIT (IC50s = 28 and 16 nM, respectively); is s… | 25 mg | 18012-25 | More Info |
| PLX647 | A dual inhibitor of FMS and KIT (IC50s = 28 and 16 nM, respectively); is s… | 5 mg | 18012-5 | More Info |
| PLX647 | A dual inhibitor of FMS and KIT (IC50s = 28 and 16 nM, respectively); is s… | 50 mg | 18012-50 | More Info |
| PLX7904 | A RAF inhibitor (IC50s = 2.4, 140, and 91 nM for mutant B-RAFV600E, wild-t… | 1 mg | 20710-1 | More Info |
| PLX7904 | A RAF inhibitor (IC50s = 2.4, 140, and 91 nM for mutant B-RAFV600E, wild-t… | 10 mg | 20710-10 | More Info |
| PLX7904 | A RAF inhibitor (IC50s = 2.4, 140, and 91 nM for mutant B-RAFV600E, wild-t… | 25 mg | 20710-25 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile